Skip to main content
ELOX
NASDAQ Life Sciences

Eloxx Posts Smaller-Than-Expected Q3 Loss of 49 Cents a Share

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.15
Mkt Cap
$53.079M
52W Low
$0
52W High
$23.4
52W Position
Off High info
44% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

Summary

Eloxx lost 49 cents a share in the September quarter, better than the 58-cent consensus from three analysts, with a net loss of $5.54 million. Revenue was zero, as expected — this is a clinical-stage story, not a sales story. The 8-K filed this morning put cash at $56.3 million, down from $62 million at the end of June, so the burn is real but the runway is still intact. The bigger driver remains the October FDA clearance of the IND for exaluren in nonsense-mutation ADPKD, which lets them start a 60-patient trial; today's beat is a modest positive on top of that. Shares are down 14.1% this quarter despite the trial green light, and the average analyst rating is buy with a median target of $39.00.

At the time of this announcement, ELOX was trading at $13.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $53.1M. The 52-week trading range was $0.00 to $23.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ELOX - Latest Insights

ELOX
Oct 29, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $13.32
Real-time Price: $12.87 info
Change: -$0.450 (-3%) info
Market Cap: $51.949M info
ELOX
Aug 12, 2026, 6:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $19.18
Real-time Price: $12.87 info
Change: -$6.31 (-33%) info
Market Cap: $51.949M info
ELOX
Aug 11, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.18
Real-time Price: $12.87 info
Change: -$6.31 (-33%) info
Market Cap: $51.949M info
ELOX
Aug 11, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $19.18
Real-time Price: $12.87 info
Change: -$6.31 (-33%) info
Market Cap: $51.949M info
ELOX
Jun 17, 2026, 5:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $12.00
Real-time Price: $12.87 info
Change: +$0.870 (+7%) info
Market Cap: $51.949M info